Becton Dickinson and Co (NYSE:BDX)
| 268.72 Delayed Data As of Dec 13 |  +3.28 / +1.24%Today’s Change | 208.62 Today|||52-Week Range 269.41 | +19.26% Year-to-Date |
Latest BDX News | Press Releases
No recent news for Becton Dickinson and Co.
Today’s Trading
| Previous close | 265.44 |
| Today’s open | 265.13 |
| Day’s range | 264.17 - 269.41 |
| Volume | 1,688,843 |
| Average volume (3 months) | 1,105,569 |
| Market cap | $72.7B |
Data as of 6:30pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | +546.77% |
| Earnings growth (this year) | +7.72% |
| Earnings growth (next 5 years) | +10.23% |
| Revenue growth (last year) | +8.18% |
| P/E ratio | 68.2 |
| Price/Sales | 4.02 |
| Price/Book | 3.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | +0.42 | +0.94% |
| BAXBaxter International... | +0.45 | +0.54% |
| ZBHZimmer Biomet Holdin... | +0.66 | +0.45% |
| DXCMDexCom Inc | +1.83 | +0.91% |
Data as of 6:30pm ET, 12/13/2019
Financials
| Next reporting date | February 11, 2020 |
| EPS forecast (this quarter) | $2.64 |
| Annual revenue (last year) | $17.3B |
| Annual profit (last year) | $1.2B |
| Net profit margin | 7.14% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |
Forecasts
